Biosimilars Market Expected to Hit US$133.39 Billion by 2033

a adăugat un sunet Alte

2026-09-09 12:02:23 -

Biosimilars are biological medicines highly similar to approved reference biologic products, developed to provide comparable therapeutic outcomes, safety profiles, and clinical effectiveness. The Biosimilars Market Share was valued at US$ 34.62 Billion in 2025 and is projected to reach US$ 133.39 Billion by 2033, growing at a CAGR of 18.37% during 2026–2033. The increasing...

0 Commentarii 0 Distribuiri 8 Views 0 previzualizare